Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Urethral Defect in Setting of Recurrent Urethral Foreign Body Insertion.

Simms A, Chappidi M, Yang H, Hampson L, Breyer B, Cohen AJ.

Urology. 2019 Nov 30. pii: S0090-4295(19)31049-0. doi: 10.1016/j.urology.2019.11.024. [Epub ahead of print]

PMID:
31794812
2.

Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop.

Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, Wilson EC, MacLennan G, Stallard N, Rothwell JC, Bland M, Brown L, Ramsay CR, Cook A, Armstrong D, Altman D, Vale LD.

Health Technol Assess. 2019 Oct;23(60):1-88. doi: 10.3310/hta23600.

3.

Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.

Sones W, Julious SA, Rothwell JC, Ramsay CR, Hampson LV, Emsley R, Walters SJ, Hewitt C, Bland M, Fergusson DA, Berlin JA, Altman D, Vale LD, Cook JA.

Trials. 2019 Oct 24;20(1):602. doi: 10.1186/s13063-019-3809-2.

4.

Developing and applying a 'living guidelines' approach to WHO recommendations on maternal and perinatal health.

Vogel JP, Dowswell T, Lewin S, Bonet M, Hampson L, Kellie F, Portela A, Bucagu M, Norris SL, Neilson J, Gülmezoglu AM, Oladapo OT.

BMJ Glob Health. 2019 Aug 19;4(4):e001683. doi: 10.1136/bmjgh-2019-001683. eCollection 2019. Review.

5.

Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.

Veeramachaneni R, Walker T, Revil T, Weck A, Badescu D, O'Sullivan J, Higgins C, Elliott L, Liloglou T, Risk JM, Shaw R, Hampson L, Hampson I, Dearden S, Woodwards R, Prime S, Hunter K, Parkinson EK, Ragoussis J, Thakker N.

Sci Rep. 2019 Aug 19;9(1):11992. doi: 10.1038/s41598-019-48229-7.

6.

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.

Ramanan AV, Hampson LV, Lythgoe H, Jones AP, Hardwick B, Hind H, Jacobs B, Vasileiou D, Wadsworth I, Ambrose N, Davidson J, Ferguson PJ, Herlin T, Kavirayani A, Killeen OG, Compeyrot-Lacassagne S, Laxer RM, Roderick M, Swart JF, Hedrich CM, Beresford MW.

PLoS One. 2019 Jun 5;14(6):e0215739. doi: 10.1371/journal.pone.0215739. eCollection 2019.

7.

Dorsal buccal graft urethroplasty in female urethral stricture disease: a multi-center experience.

Hampson LA, Myers JB, Vanni AJ, Virasoro R, Smith TG 3rd, Capiel L, Chandrapal J, Voelzke BB.

Transl Androl Urol. 2019 Mar;8(Suppl 1):S6-S12. doi: 10.21037/tau.2019.03.02.

8.

Sarcome-13/OS2016 trial protocol: a multicentre, randomised, open-label, phase II trial of mifamurtide combined with postoperative chemotherapy for patients with newly diagnosed high-risk osteosarcoma.

Brard C, Piperno-Neumann S, Delaye J, Brugières L, Hampson LV, Le Teuff G, Le Deley MC, Gaspar N.

BMJ Open. 2019 May 19;9(5):e025877. doi: 10.1136/bmjopen-2018-025877.

9.

Operating Room Supply Cost Awareness: A Cross-Sectional Analysis.

Schmidt B, Meng MV, Hampson LA.

Urol Pract. 2019 Mar;6(2):73-78. doi: 10.1016/j.urpr.2018.04.003. Epub 2018 Apr 27.

PMID:
31106254
10.

Incorporating Innovative Techniques Toward Extrapolation and Efficient Pediatric Drug Development.

Gamalo-Siebers M, Hampson L, Kordy K, Weber S, Nelson RM, Portman R.

Ther Innov Regul Sci. 2019 Sep;53(5):567-578. doi: 10.1177/2168479019842541. Epub 2019 May 13.

PMID:
31084211
11.

Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.

Brard C, Hampson LV, Gaspar N, Le Deley MC, Le Teuff G.

BMC Med Res Methodol. 2019 Apr 24;19(1):85. doi: 10.1186/s12874-019-0714-z.

12.

The Impact of Frailty on Artificial Urinary Sphincter Placement and Removal Procedures.

Medendorp AR, Anger JT, Jin C, Amin KA, Hampson LA, Lee UJ, Suskind AM.

Urology. 2019 Jul;129:210-216. doi: 10.1016/j.urology.2019.04.015. Epub 2019 Apr 19.

13.

Long-term follow-up of urethral reconstruction for blunt urethral injury at a young age: urinary and sexual quality of life outcomes.

Baradaran N, McAninch JW, Copp HL, Quanstrom K, Breyer BN, Hampson LA.

J Pediatr Urol. 2019 May;15(3):224.e1-224.e6. doi: 10.1016/j.jpurol.2019.02.013. Epub 2019 Mar 6.

14.

Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873.

Jaki T, Gordon A, Forster P, Bijnens L, Bornkamp B, Brannath W, Fontana R, Gasparini M, Hampson LV, Jacobs T, Jones B, Paoletti X, Posch M, Titman A, Vonk R, Koenig F.

Pharm Stat. 2019 May;18(3):284-286. doi: 10.1002/pst.1942. Epub 2019 Mar 14. No abstract available.

PMID:
30868716
15.

Variation in Laparoscopic Nephrectomy Surgical Costs: Opportunities for High Value Care Delivery.

Hampson LA, Odisho AY, Meng MV.

Urol Pract. 2018 Sep;5(5):334-341. doi: 10.1016/j.urpr.2017.09.003.

16.

A robust Bayesian meta-analytic approach to incorporate animal data into phase I oncology trials.

Zheng H, Hampson LV, Wandel S.

Stat Methods Med Res. 2019 Jan 16:962280218820040. doi: 10.1177/0962280218820040. [Epub ahead of print]

PMID:
30648481
17.

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.

Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, Wilson ECF, MacLennan G, Stallard N, Rothwell JC, Bland M, Brown L, Ramsay CR, Cook A, Armstrong D, Altman D, Vale LD.

BMJ. 2018 Nov 5;363:k3750. doi: 10.1136/bmj.k3750. No abstract available.

18.

AUTHOR REPLY.

Voelzke BB, Sinanan M, Hampson LA.

Urology. 2018 Nov;121:181. doi: 10.1016/j.urology.2018.06.072. No abstract available.

PMID:
30526905
19.

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.

Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, Wilson ECF, Maclennan G, Stallard N, Rothwell JC, Bland M, Brown L, Ramsay CR, Cook A, Armstrong D, Altman D, Vale LD.

Trials. 2018 Nov 5;19(1):606. doi: 10.1186/s13063-018-2884-0.

20.

Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.

Sones W, Julious SA, Rothwell JC, Ramsay CR, Hampson LV, Emsley R, Walters SJ, Hewitt C, Bland M, Fergusson DA, Berlin JA, Altman D, Vale LD, Cook JA.

Trials. 2018 Oct 10;19(1):542. doi: 10.1186/s13063-018-2887-x. Erratum in: Trials. 2019 Oct 24;20(1):602.

21.

Does routine repeat imaging change management in high-grade renal trauma? Results from three level 1 trauma centers.

Bayne DB, Tresh A, Baradaran N, Murphy G, Osterberg EC, Ogawa S, Wenzel J, Hampson L, McAninch J, Breyer B.

World J Urol. 2019 Jul;37(7):1455-1459. doi: 10.1007/s00345-018-2513-2. Epub 2018 Oct 1.

PMID:
30276541
22.

Long-term complications of continent catheterizable channels: a problem for transitional urologists.

Hampson LA, Baradaran N, Elliott SP.

Transl Androl Urol. 2018 Aug;7(4):558-566. doi: 10.21037/tau.2018.03.26. Review.

23.

Outcomes and Quality of Life Among Men After Anal Sphincter-Sparing Transperineal Rectourethral Fistula Repair.

Hampson LA, Muncey W, Sinanan MN, Voelzke BB.

Urology. 2018 Nov;121:175-181. doi: 10.1016/j.urology.2018.06.052. Epub 2018 Sep 4.

24.

A proposal for a new PhD level curriculum on quantitative methods for drug development.

Jaki T, Gordon A, Forster P, Bijnens L, Bornkamp B, Brannath W, Fontana R, Gasparini M, Hampson LV, Jacobs T, Jones B, Paoletti X, Posch M, Titman A, Vonk R, Koenig F.

Pharm Stat. 2018 Sep;17(5):593-606. doi: 10.1002/pst.1873. Epub 2018 Jul 9.

25.

Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and Opportunities.

Lim J, Walley R, Yuan J, Liu J, Dabral A, Best N, Grieve A, Hampson L, Wolfram J, Woodward P, Yong F, Zhang X, Bowen E.

Ther Innov Regul Sci. 2018 Sep;52(5):546-559. doi: 10.1177/2168479018778282. Epub 2018 Jun 18.

PMID:
29909645
26.

Patient-Reported Outcome Measures in Urethral Reconstruction.

Baradaran N, Hampson LA, Edwards TC, Voelzke BB, Breyer BN.

Curr Urol Rep. 2018 May 17;19(7):48. doi: 10.1007/s11934-018-0797-9. Review.

27.

Genital burns in the United States: Disproportionate prevalence in the pediatric population.

Tresh A, Baradaran N, Gaither TW, Fergus KB, Liaw A, Balakrishnan A, Hampson LA, Breyer BN.

Burns. 2018 Aug;44(5):1366-1371. doi: 10.1016/j.burns.2018.02.023. Epub 2018 Mar 22.

28.

Adaptive designs in clinical trials: why use them, and how to run and report them.

Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, Holmes J, Mander AP, Odondi L, Sydes MR, Villar SS, Wason JMS, Weir CJ, Wheeler GM, Yap C, Jaki T.

BMC Med. 2018 Feb 28;16(1):29. doi: 10.1186/s12916-018-1017-7.

29.

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.

Cook N, Basu B, Smith DM, Gopinathan A, Evans J, Steward WP, Palmer D, Propper D, Venugopal B, Hategan M, Anthoney DA, Hampson LV, Nebozhyn M, Tuveson D, Farmer-Hall H, Turner H, McLeod R, Halford S, Jodrell D.

Br J Cancer. 2018 Mar 20;118(6):793-801. doi: 10.1038/bjc.2017.495. Epub 2018 Feb 13.

30.

Conservative Management of High-grade Renal Trauma Does Not Lead to Prolonged Hospital Stay.

Hampson LA, Radadia KD, Odisho AY, McAninch JW, Breyer BN.

Urology. 2018 May;115:92-95. doi: 10.1016/j.urology.2017.11.018. Epub 2018 Apr 2.

31.

Surgical and Functional Outcomes Following Buried Penis Repair With Limited Panniculectomy and Split-thickness Skin Graft.

Hampson LA, Muncey W, Chung PH, Ma CC, Friedrich J, Wessells H, Voelzke BB.

Urology. 2017 Dec;110:234-238. doi: 10.1016/j.urology.2017.07.021. Epub 2017 Aug 7.

PMID:
28797684
32.

Understanding patients' preferences for surgical management of urethral stricture disease.

Hampson LA, Lin TK, Wilson L, Allen IE, Gaither TW, Breyer BN.

World J Urol. 2017 Nov;35(11):1799-1805. doi: 10.1007/s00345-017-2066-9. Epub 2017 Jun 29.

33.

Variation and Predictors of Surgical Case Costs among Urologists.

Hampson LA, Odisho AY, Meng MV, Carroll PR.

Urol Pract. 2017 Jul;4(4):277-284. doi: 10.1016/j.urpr.2016.07.005. Epub 2016 Oct 15.

34.

Many-to-one comparisons after safety selection in multi-arm clinical trials.

Hlavin G, Hampson LV, Koenig F.

PLoS One. 2017 Jun 26;12(6):e0180131. doi: 10.1371/journal.pone.0180131. eCollection 2017.

35.

Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation.

Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E, Epps H, Main M, Geary M, McMurchie H, Pallant L, Woods D, Freeman J, Lee E, Eagle M, Willis T, Muntoni F, Baxter P.

Health Technol Assess. 2017 May;21(27):1-120. doi: 10.3310/hta21270.

36.

Choosing the target difference ('effect size') for a randomised controlled trial - DELTA2 guidance protocol.

Cook JA, Julious SA, Sones W, Rothwell JC, Ramsay CR, Hampson LV, Emsley R, Walters SJ, Hewitt C, Bland M, Fergusson DA, Berlin JA, Altman D, Vale LD.

Trials. 2017 Jun 12;18(1):271. doi: 10.1186/s13063-017-1969-5. Review.

37.

A framework for prospectively defining progression rules for internal pilot studies monitoring recruitment.

Hampson LV, Williamson PR, Wilby MJ, Jaki T.

Stat Methods Med Res. 2018 Dec;27(12):3612-3627. doi: 10.1177/0962280217708906. Epub 2017 Jun 7.

PMID:
28589752
38.

Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial.

Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E, Epps H, Main M, Geary M, McMurchie H, Pallant L, Woods D, Freeman J, Lee E, Eagle M, Willis T, Muntoni F, Baxter P.

Pilot Feasibility Stud. 2017 Mar 27;3:16. doi: 10.1186/s40814-017-0132-0. eCollection 2017.

39.

Low-Volume vs High-Volume Centers and Management of Fournier's Gangrene in Washington State.

Osbun N, Hampson LA, Holt SK, Gore JL, Wessells H, Voelzke BB.

J Am Coll Surg. 2017 Mar;224(3):270-275.e1. doi: 10.1016/j.jamcollsurg.2016.11.012. Epub 2016 Dec 10.

PMID:
27965132
40.

Asymmetric inner wedge group sequential tests with applications to verifying whether effective drug concentrations are similar in adults and children.

Hampson LV, Fisch R, Van LM, Jaki T.

Stat Med. 2017 Feb 10;36(3):426-441. doi: 10.1002/sim.7154. Epub 2016 Nov 8.

PMID:
27859519
41.

Reply.

Hampson LA, Breyer BN.

Urology. 2017 Jan;99:252-253. doi: 10.1016/j.urology.2016.07.055. Epub 2016 Nov 11. No abstract available.

PMID:
27842987
42.

"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?

Eichler HG, Bloechl-Daum B, Bauer P, Bretz F, Brown J, Hampson LV, Honig P, Krams M, Leufkens H, Lim R, Lumpkin MM, Murphy MJ, Pignatti F, Posch M, Schneeweiss S, Trusheim M, Koenig F.

Clin Pharmacol Ther. 2016 Dec;100(6):699-712. doi: 10.1002/cpt.515. Epub 2016 Oct 19.

43.

Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation.

Wadsworth I, Jaki T, Sills GJ, Appleton R, Cross JH, Marson AG, Martland T, McLellan A, Smith PE, Pellock JM, Hampson LV.

CNS Drugs. 2016 Nov;30(11):1011-1017. Review.

44.

Multicenter Analysis of Urinary Urgency and Urge Incontinence in Patients with Anterior Urethral Stricture Disease before and after Urethroplasty.

Hampson LA, Elliott SP, Erickson BA, Vanni AJ, Myers JB, McClung C, Breyer BN, Smith TG 3rd, Hagedorn JC, Voelzke BB; TURNS.

J Urol. 2016 Dec;196(6):1700-1705. doi: 10.1016/j.juro.2016.08.015. Epub 2016 Aug 10.

45.

Bayesian survival analysis in clinical trials: What methods are used in practice?

Brard C, Le Teuff G, Le Deley MC, Hampson LV.

Clin Trials. 2017 Feb;14(1):78-87. doi: 10.1177/1740774516673362. Epub 2016 Oct 11. Review.

PMID:
27729499
46.

Patient-centered Treatment Decisions for Urethral Stricture: Conjoint Analysis Improves Surgical Decision-making.

Hampson LA, Allen IE, Gaither TW, Lin T, Ting J, Osterberg EC, Wilson L, Breyer BN.

Urology. 2017 Jan;99:246-253. doi: 10.1016/j.urology.2016.07.053. Epub 2016 Sep 16.

47.

Analysis of the Prevalence of HTLV-1 Proviral DNA in Cervical Smears and Carcinomas from HIV Positive and Negative Kenyan Women.

He X, Maranga IO, Oliver AW, Gichangi P, Hampson L, Hampson IN.

Viruses. 2016 Sep 5;8(9). pii: E245. doi: 10.3390/v8090245.

48.

Silver nanoparticles exhibit size-dependent differential toxicity and induce expression of syncytin-1 in FA-AML1 and MOLT-4 leukaemia cell lines.

Alqahtani S, Promtong P, Oliver AW, He XT, Walker TD, Povey A, Hampson L, Hampson IN.

Mutagenesis. 2016 Nov;31(6):695-702. Epub 2016 Aug 30.

PMID:
27576335
49.

Identification of Organ-Enriched Protein Biomarkers of Acute Liver Injury by Targeted Quantitative Proteomics of Blood in Acetaminophen- and Carbon-Tetrachloride-Treated Mouse Models and Acetaminophen Overdose Patients.

Qin S, Zhou Y, Gray L, Kusebauch U, McEvoy L, Antoine DJ, Hampson L, Park KB, Campbell D, Caballero J, Glusman G, Yan X, Kim TK, Yuan Y, Wang K, Rowen L, Moritz RL, Omenn GS, Pirmohamed M, Hood L.

J Proteome Res. 2016 Oct 7;15(10):3724-3740. Epub 2016 Sep 19.

PMID:
27575953
50.

Major genitourinary-related bicycle trauma: Results from 20 years at a level-1 trauma center.

Osterberg EC, Awad MA, Gaither TW, Sanford T, Alwaal A, Hampson LA, Yoo J, McAninch JW, Breyer BN.

Injury. 2017 Jan;48(1):153-157. doi: 10.1016/j.injury.2016.07.006. Epub 2016 Jul 5.

Supplemental Content

Loading ...
Support Center